Enterprise

Canopy Growth Accelerates Entry Into U.S. Market

Canopy Growth, whose U.S. footprint currently spans 21 states, announced plans to accelerate its entry into the U.S. market. It will expand its portfolio to include the purchase of multi-state operator Acreage Holdings, California-based extractor Jetty Extracts, and edibles maker Wana Brands. The company plans "to unleash the full power of Canopy in the U.S. cannabis ecosystem."

Last week, Canadian cannabis company Canopy Growth announced plans to accelerate its entry into the U.S. market. The company said it was consolidating its U.S. assets into a new company, Canopy USA.

To keep up with the latest in cannabis company updates, download our free cannabis news app.

Canopy Growth Expands U.S. Portfolio

Canopy’s U.S. portfolio will include the purchase of multi-state operator Acreage Holdings, California-based extractor Jetty Extracts, and edibles maker Wana Brands.

Canopy Growth had initially agreed to buy the latter once U.S. federal law had legalized cannabis. However, Canopy decided not to wait for U.S. federal legalization.

Canopy Growth Seeks to “Take Control” of its Destiny

David Klein, Canopy Growth’s CEO, said the strategy will allow the company “to take control” of its destiny “and to capitalize on the unique opportunity presented by the world’s largest cannabis market.”

“We plan to unleash the full power of Canopy in the U.S. cannabis ecosystem to unlock potential expansion opportunities. This strategy and positioning are true differentiators that we believe will allow our investors and brands to realize near-term value while positioning Canopy for profitable growth and a quick startup upon receipt of U.S. federal approval,” David Klein explained in a press release.

The deal could take a year and a half to complete. However, the time span depends on the necessary approvals from the U.S. economic authorities and the various boards of the companies to be acquired.

Constellation Brands to Take a More Passive Role

Constellation Brands, the spirits giant that put more than $4 billion into Canopy, said it plans to return to a more passive, non-voting role. The liquor maker will retain its current stake but will no longer be allowed to appoint representatives to Canopy’s board or approve certain transactions. It also will not have the right to review Canopy’s financial results.

“This transaction and the relinquishment of our warrants should eliminate the impact on our earnings interest, mitigate the risk to our organization, and reinforce our intention not to deploy additional investments in Canopy, consistent with Constellation’s previously stated capital allocation priorities,” said Bill Newlands, Constellation’s president and chief executive officer.

Canopy Growth Footprint Spans 21 U.S. States

Collectively, Canopy Growth’s footprint currently spans 21 U.S. states, including Arizona, Arkansas, California, Colorado, Connecticut, Florida, Illinois, Maine, Maryland, Massachusetts, Michigan, Missouri, Nevada, New Hampshire, New Jersey, New Mexico, New York, Pennsylvania, Ohio, Oklahoma, and Oregon.

(Featured image by Richard T via Unsplash)

DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the company may believe that its expectations are based on reasonable assumptions, the actual results that the company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in Newsweed, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Angelique Moss

Angelique Moss is a London-based entrepreneur, writer, and traveller. The world of business, finance, and technology, is her preferred cup of tea. She also writes about the developments and discussions on health, art, luxury and media. A top writer for several Medium publications, she has published hundreds of widely read articles on investing, stocks, global markets, cannabis, and technology for multiple platforms. She is also interested in culture, history, and social affairs.

Recent Posts

The Fall of an Icon: High Times and the Inevitable Auction of the Iconic Cannabis Brand

High Times, once a leading cannabis culture magazine, faces severe financial troubles, prompting a potential…

18 hours ago

DEA Agrees to Reclassify Cannabis as a “Less Dangerous” Substance

The DEA plans to reclassify cannabis from Schedule I to Schedule III of the Controlled…

1 day ago

Pillar 2 Cannabis Pilot Program to Launch in Germany

Germany is advancing its cannabis policy by launching Pillar 2, which involves five-year pilot projects…

5 days ago

Rolling Papers May Contain Traces of Heavy Metals, Study Finds

A new study has revealed that rolling papers can contain heavy metals and chemical residues…

7 days ago

Bitcoin – The Ideal Payment System for a Thriving Cannabis Industry

Bitcoin could serve as a decentralized, stable alternative for the cannabis industry, promoting financial autonomy…

1 week ago

Medical Cannabis Effectiveness Confirmed By Over 80% of Patients

Over 80% of participants in a German study reported that medical cannabis was effective in…

1 week ago